[Teicoplanin in otorhinolaryngology].

In this study the clinical microbiologic efficacy of a new antibiotic, Teicoplanin, has been reported. Teicoplanin was given to both male and female patients (200 or 400 mg/die doses) suffering from ORL infections. The microbial flora of the inflammatory focus was checked before and after antibiotic administration. Complete microbiologic eradication occurred in 13 cases of the 18 examined; in 3 cases was observed reinfection and in 2 cases the isolates were not sensitive to the antibiotic tested.